Gilteritinib: Targeted Therapy for FLT3-Mutated AML Gilteritinib is a breakthrough oral medication used in the treatment of acute myeloid leukemia (AML), specifically for patients with a FLT3 gene mutation. As…
Selpercatinib (RETEVMO): A Breakthrough Targeted Therapy for RET-Driven Cancers What is Selpercatinib? Selpercatinib, marketed under the brand name RETEVMO, is an FDA-approved targeted therapy developed for the treatment of cancers…
Dacomitinib: Uses, Dosage, Side Effects & More Dacomitinib is a prescription medication used for the treatment of non-small cell lung cancer (NSCLC). As a targeted therapy, it works by inhibiting…
Reviews
There are no reviews yet.